TMPRSS3

Chr 21AR

transmembrane serine protease 3

Also known as: DFNB10, DFNB8, ECHOS1, TADG12

This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 1.121 OMIM phenotype
Clinical SummaryTMPRSS3
🧬
Gene-Disease Validity (ClinGen)
nonsyndromic genetic hearing loss · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
122 unique Pathogenic / Likely Pathogenic· 160 VUS of 676 total submissions
📖
GeneReview available — TMPRSS3
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.12LOEUF
pLI 0.000
Z-score 1.10
OE 0.76 (0.531.12)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.57Z-score
OE missense 1.10 (1.001.21)
284 obs / 258.4 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.76 (0.531.12)
00.351.4
Missense OE?1.10 (1.001.21)
00.61.4
Synonymous OE?1.25
01.21.6
LoF obs/exp: 19 / 24.9Missense obs/exp: 284 / 258.4Syn Z: -2.12

This gene — mechanism propensity

DN
0.6258th %ile
GOF
0.6737th %ile
LOF
0.3453th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

676 submitted variants in ClinVar

Classification Summary

Pathogenic53
Likely Pathogenic69
VUS160
Likely Benign277
Benign51
Conflicting53
53
Pathogenic
69
Likely Pathogenic
160
VUS
277
Likely Benign
51
Benign
53
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
35
12
6
0
53
Likely Pathogenic
28
39
2
0
69
VUS
0
113
43
4
160
Likely Benign
0
8
127
142
277
Benign
1
3
45
2
51
Conflicting
53
Total64175223148663

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

84 pathogenic / likely-pathogenic (of 99) ClinVar copy-number / structural variants overlap TMPRSS3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TMPRSS3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →